Articles Tagged With:
-
Prying Eyes Put EDs at High Risk for HIPAA Violations
Ensure policies are in place to protect the privacy of patients’ identifiable health information, train staff on those policies, implement measures to maximize compliance with the policies, and provide supplemental training if there are any incidents of non-compliance by an individual or group.
-
Make Headway Against Workplace Violence with Data Tracking, Interdisciplinary Initiatives
Two health systems have started several initiatives that attack the problem from different angles. Data show these systems are making a sizable dent in incidents of violence in their EDs and other vulnerable points. These leaders are sharing their roadmaps and best practices so others can benefit.
-
Prioritize Bed Placement for Older Patients to Shorten Stays, Prevent Delirium
A team of emergency physicians gathered data showing that among older patients, there is an association between time spent in the ED and the development of delirium. Researchers found that for every hour spent in the ED, the risk of developing delirium increased by roughly 2%.
-
To Alleviate Boarding, Consider Creating Discharge Lounge
Several months into the new process, leaders at Northwestern Medicine Palos Hospital report they have shortened the average discharge process from four hours to one hour, they have halved the ED’s leave-without-being-seen rate, and patient satisfaction scores have begun to rise in both the ED and inpatient settings.
-
Consensus Panel Offers Guidance for Pediatric Mental Health Boarding
EDs nationwide continue to see pediatric mental health patients boarded in the department for long periods while awaiting inpatient bed placement. A group of 23 experts from 17 health systems sought to identify what EDs are facing, to learn how departments are handling the problem, and to offer recommendations to standardize practices.
-
Boarded Mental Health Patients: Out of Sight, Out of Mind
Many EDs routinely board mental health patients for days on end, awaiting transfer to a mental health facility. An expert offers tips to help emergency medicine providers alleviate safety and medical/legal risks.
-
Disease-Modifying Therapy After Natalizumab Discontinuation in Patients with Relapsing Multiple Sclerosis
In this retrospective cohort study, the investigators found that, when compared to fingolimod and dimethyl fumarate, ocrelizumab use was associated with significantly lower annualized relapse rate and treatment discontinuation. There were no significant differences in outcomes between fingolimod and dimethyl fumarate use. Ocrelizumab use was associated with a lower rate of disability accumulation when compared to fingolimod.
-
Treatment of Psychotic Symptoms in Alzheimer’s Disease
In a meta-analysis of several large treatment trials of patients with Alzheimer’s disease, Parkinson’s disease, and dementia with Lewy bodies, cholinesterase inhibitors demonstrated a small but statistically significant benefit in reducing psychotic symptoms.
-
Antidepressants for Chronic Pain: Do They Work?
Antidepressant medications have been widely used for treating a variety of chronic pain disorders but strong evidence to support their efficacy is lacking. Some patients may respond, but available data do not help us to determine which agents may be helpful in a specific type of chronic pain condition.
-
Celery Seed-Derived Compound: A Legitimate Neuroprotectant for Acute Ischemic Stroke?
A Phase III double-blind, placebo-controlled, randomized controlled trial suggests that early administration of DL-3-n-butylphthalide, when given adjunctively to thrombolysis or endovascular therapy, improves functional outcomes in patients with acute ischemic stroke. Statistically significant results of well-designed analyses are tantalizing, but confidence in the findings is tempered by a lack of generalizability, an unclear mechanism of action, and trial design irregularities.